Lung stereotactic body radiotherapy after past ablative therapy: a single institution case series
{{output}}
Aim: Non-small-cell lung cancer recurs locally 10-40% of the time after local therapy, presenting a therapeutic challenge given poor pulmonary reserve. Herein, we seek to evaluate the safety and efficacy of stereotactic body radi... ...
